ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,884,000 | -68.0% | 265,365 | -67.5% | 0.01% | -69.7% |
Q1 2022 | $5,886,000 | -43.5% | 815,277 | -30.0% | 0.03% | -42.1% |
Q4 2021 | $10,410,000 | +15.3% | 1,164,467 | +352.4% | 0.06% | -1.7% |
Q3 2021 | $9,025,000 | +50.9% | 257,416 | -7.6% | 0.06% | +41.5% |
Q2 2021 | $5,981,000 | – | 278,450 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
CM Management, LLC | 275,000 | $825,000 | 0.88% |
Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
Diametric Capital, LP | 200,000 | $600,000 | 0.25% |